15 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 15 of 15 clinical reviews.
Evidence-based guide to safely discontinuing methimazole (Tapazole) for hyperthyroidism and Graves' disease, including taper schedules, lab monitoring, relapse predictors, and when definitive therapy may be preferred.
A guide to how methimazole affects appetite and food cravings in hyperthyroid patients, including the thyroid-metabolic axis, expected timelines, and when appetite changes signal a problem.
A clinician-grade guide to methimazole drug interactions, covering warfarin, beta-blockers, digoxin, theophylline, iodinated contrast, and more, with PubMed-cited evidence.
A comparison of compounded methimazole versus branded Tapazole covering bioavailability, cost, dosing, safety, and when each formulation is appropriate for hyperthyroidism and Graves disease management.
A full clinical review of methimazole-induced and hyperthyroidism-related hair and skin changes, including alopecia, urticaria, and vasculitis, with primary-literature citations and management guidance.
Evidence-based guide to methimazole use during pregnancy and breastfeeding, including first-trimester teratogenicity risks, PTU switching protocols, and lactation compatibility data.
Miss a methimazole dose? Take it when you remember unless your next dose is under 4 hours away, then skip it. Never double up; one lapse rarely spikes T4.
Complete guide to methimazole (Tapazole) monitoring in young adults aged 18-29. Covers CBC, liver function, thyroid panels, fertility considerations, and when to call your doctor.
A clinical deep-dive into methimazole (Tapazole) ADME pharmacokinetics, including bioavailability, thyroid gland concentration, hepatic metabolism, renal elimination, and dose-response implications for hyperthyroidism treatment.
A clinical guide to the risk of hyperthyroidism returning after stopping methimazole: who is more likely to relapse, what the evidence actually supports, how tapering is typically approached, and when to escalate to definitive therapy.
A clinical review of methimazole safety signals, FDA warnings, boxed label changes, and post-market adverse event data for hyperthyroidism and Graves disease treatment.
Evidence-based guide to methimazole (Tapazole) storage conditions, chemical stability data, shelf life, and practical handling for patients and pharmacies.
Starting doses run 10 to 40 mg/day, tapering to 5 to 10 mg maintenance after 4 to 8 weeks. About 50% reach remission by 12 to 18 months.
Learn which foods and supplements affect thyroid function, distort thyroid tests, or follow another medicine’s timing rules while taking methimazole.
Evidence-based guide to switching between methimazole and propylthiouracil, radioactive iodine, or thyroidectomy. Covers dose conversion ratios, pregnancy protocols, and monitoring timelines.